Béland MA et al. |
Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study. |
2017 |
Transpl. Int. |
pmid:28186642
|
Colombo M et al. |
Influence of Drug Brittleness, Nanomilling Time, and Freeze-Drying on the Crystallinity of Poorly Water-Soluble Drugs and Its Implications for Solubility Enhancement. |
2017 |
AAPS PharmSciTech |
pmid:28168626
|
Saliba F et al. |
Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial. |
2017 |
Am. J. Transplant. |
pmid:28133906
|
de Fijter JW et al. |
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial. |
2017 |
Am. J. Transplant. |
pmid:28027625
|
Sukkha S et al. |
Trough level from twice daily to once daily tacrolimus in early conversion kidney transplant recipients: a prospective study. |
2017 |
Int J Clin Pharm |
pmid:29101615
|
Elens L and Haufroid V |
Genotype-based tacrolimus dosing guidelines: with or without CYP3A4*22? |
2017 |
Pharmacogenomics |
pmid:29095105
|
Song L et al. |
ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys. |
2017 |
Am. J. Transplant. |
pmid:27598231
|
Sopko NA et al. |
Ex Vivo Model of Human Penile Transplantation and Rejection: Implications for Erectile Tissue Physiology. |
2017 |
Eur. Urol. |
pmid:27432525
|
Al-Uzri A et al. |
Longitudinal study on the use of dried blood spots for home monitoring in children after kidney transplantation. |
2017 |
Pediatr Transplant |
pmid:28635157
|
Ma X et al. |
Inhibition effect of tacrolimus and platelet-derived growth factor-BB on restenosis after vascular intimal injury. |
2017 |
Biomed. Pharmacother. |
pmid:28633129
|
Ekman-Joelsson BM et al. |
Post-transplant lymphoproliferative disease is associated with early sternotomy and left ventricular hypoplasia during infancy: a population-based retrospective review. |
2017 |
Cardiol Young |
pmid:28780922
|
Saburi M et al. |
Effects of calcineurin inhibitors on sodium excretion in recipients of allogeneic hematopoietic stem cell transplantation. |
2017 |
Int. J. Hematol. |
pmid:28516402
|
Ferreira A et al. |
Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus. |
2017 |
Am. J. Nephrol. |
pmid:28511172
|
Gu K et al. |
Atypical pneumonia due to human bocavirus in an immunocompromised patient. |
2017 |
CMAJ |
pmid:28507089
|
Ren S et al. |
Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis. |
2017 |
PLoS ONE |
pmid:28898290
|
Sanghavi K et al. |
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients. |
2017 |
Pharmacogenomics J. |
pmid:26667830
|
Wilkes SR et al. |
More Atopic Dermatitis Trials Using Standard Treatments as Active Comparators, Please. |
2017 |
J. Invest. Dermatol. |
pmid:28249793
|
Piñana JL et al. |
A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis. |
2017 |
Biol. Blood Marrow Transplant. |
pmid:28396159
|
Heemann U and Viklicky O |
Is trough level variability the new tool for identifying patients at risk for rejection after transplantation? |
2017 |
Nephrol. Dial. Transplant. |
pmid:28186537
|
Gnarra M et al. |
Low-Dose Cyclosporine A in the Treatment of Severe Atopic Dermatitis Complicated by Chronic Hepatitis C Virus Infection. |
2017 |
Pediatr Dermatol |
pmid:28382768
|
Undre N and Dickinson J |
Relative bioavailability of single doses of prolonged-release tacrolimus administered as a suspension, orally or via a nasogastric tube, compared with intact capsules: a phase 1 study in healthy participants. |
2017 |
BMJ Open |
pmid:28377389
|
Størset E et al. |
Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'. |
2017 |
Br J Clin Pharmacol |
pmid:28374426
|
Wen Y et al. |
Inhibition of Calcineurin A by FK506 Suppresses Seizures and Reduces the Expression of GluN2B in Membrane Fraction. |
2017 |
Neurochem. Res. |
pmid:28299629
|
Forns X et al. |
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study. |
2017 |
Transpl Infect Dis |
pmid:28295849
|
Ericzon BG et al. |
Pharmacokinetics of prolonged-release tacrolimus versus immediate-release tacrolimus in de novo liver transplantation: A randomized phase III substudy. |
2017 |
Clin Transplant |
pmid:28295581
|
Wojciechowski D et al. |
Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients. |
2017 |
Clin Transplant |
pmid:28190259
|
Lum EL et al. |
Acute Kidney Allograft Rejection Precipitated by Lenalidomide Treatment for Multiple Myeloma. |
2017 |
Am. J. Kidney Dis. |
pmid:28189378
|
Xie Y et al. |
Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance. |
2017 |
Transplantation |
pmid:28187014
|
Smolders EJ et al. |
Decreased tacrolimus plasma concentrations during HCV therapy: a drug-drug interaction or is there an alternative explanation? |
2017 |
Int. J. Antimicrob. Agents |
pmid:28185946
|
Wang J et al. |
The correlation between the expression of genes involved in drug metabolism and the blood level of tacrolimus in liver transplant receipts. |
2017 |
Sci Rep |
pmid:28611384
|
Sakurai K et al. |
Efficacy of combination therapy with tacrolimus and mizoribine for cyclophosphamide-resistant ANCA-associated glomerulonephritis. |
2017 |
Int J Rheum Dis |
pmid:28205382
|
Arroyo Hornero R et al. |
CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression. |
2017 |
Transplantation |
pmid:28118317
|
Liu MZ et al. |
IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients. |
2017 |
Acta Pharmacol. Sin. |
pmid:28112181
|
Nishiya Y et al. |
A new efficient method of generating photoaffinity beads for drug target identification. |
2017 |
Bioorg. Med. Chem. Lett. |
pmid:28108248
|
Herskovitz J et al. |
Immune Suppression During Preclinical Drug Development Mitigates Immunogenicity-Mediated Impact on Therapeutic Exposure. |
2017 |
AAPS J |
pmid:28070711
|
Noguchi A et al. |
Differences in therapeutic effects of topically applied corticosteroid and tacrolimus on atopic dermatitis-like symptoms in NC/Nga mice. |
2017 |
J. Dermatol. Sci. |
pmid:28069324
|
Wungwattana M and Savic M |
Tacrolimus interaction with nafcillin resulting in significant decreases in tacrolimus concentrations: A case report. |
2017 |
Transpl Infect Dis |
pmid:28067989
|
MartÃn-Fernández M et al. |
Effects of Cyclosporine, Tacrolimus, and Rapamycin on Osteoblasts. |
2017 |
Transplant. Proc. |
pmid:29149986
|
Liberal R et al. |
Expert clinical management of autoimmune hepatitis in the real world. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28004405
|
Størset E et al. |
Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance. |
2017 |
Br J Clin Pharmacol |
pmid:28008657
|
Segal JP et al. |
Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28008631
|
Nakamura K et al. |
AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts. |
2017 |
Eur. J. Pharmacol. |
pmid:27993641
|
Goldsmith PM et al. |
Impact of intrapatient variability (IPV) in tacrolimus trough levels on long-term renal transplant function: multicentre collaborative retrospective cohort study protocol. |
2017 |
BMJ Open |
pmid:28756385
|
Lewis DJ et al. |
Oral bexarotene for post-transplant cutaneous T-cell lymphoma. |
2017 |
Dermatol Ther |
pmid:28748653
|
Gelens MACJ et al. |
No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12years tacrolimus exposure. |
2017 |
J. Diabetes Complicat. |
pmid:28720321
|
Theile D et al. |
Clementine juice has the potential for drug interactions - In vitro comparison with grapefruit and mandarin juice. |
2017 |
Eur J Pharm Sci |
pmid:27890698
|
Chen P et al. |
Dynamic effects of CYP3A5 polymorphism on dose requirement and trough concentration of tacrolimus in renal transplant recipients. |
2017 |
J Clin Pharm Ther |
pmid:27885697
|
Grinyó JM et al. |
Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial. |
2017 |
Am. J. Kidney Dis. |
pmid:27889299
|
Chucair-Elliott AJ et al. |
Colony Stimulating Factor-1 Receptor Expressing Cells Infiltrating the Cornea Control Corneal Nerve Degeneration in Response to HSV-1 Infection. |
2017 |
Invest. Ophthalmol. Vis. Sci. |
pmid:28903153
|
Zhang W et al. |
Isoglycyrrhizinate Magnesium Enhances Hepatoprotective Effect of FK506 on Ischemia-Reperfusion Injury Through HMGB1 Inhibition in a Rat Model of Liver Transplantation. |
2017 |
Transplantation |
pmid:28885495
|